Engineering CAR-T cells
Abstract Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. Afte...
Main Authors: | Cheng Zhang, Jun Liu, Jiang F. Zhong, Xi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-017-0102-y |
Similar Items
-
Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
by: Belén Blanco, et al.
Published: (2020-08-01) -
T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors
by: Nicholas J. Chandler, et al.
Published: (2020-10-01) -
Engineering switchable and programmable universal CARs for CAR T therapy
by: Delong Liu, et al.
Published: (2019-07-01) -
Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01) -
CAR T cells in solid tumors: challenges and opportunities
by: Faroogh Marofi, et al.
Published: (2021-01-01)